Survodutide

Survodutide – Research-Grade GLP-1 / Glucagon Receptor Dual Agonist Analog

Survodutide is a synthetic peptide analog engineered as a dual agonist targeting the glucagon-like peptide-1 (GLP-1) and glucagon receptors, incorporating a fatty-acid modification that promotes albumin association and extended stability in experimental systems. This dual-receptor design distinguishes Survodutide from single-receptor incretin analogs and from native endogenous peptides, and it is frequently referenced in laboratory research alongside metabolic and hepatic (MASH-model) investigational frameworks. In laboratory research settings, Survodutide is utilized as a reference material for studying multi-receptor peptide interaction models, comparative signaling pathway cross-talk, and structure–activity relationships across incretin and glucagon receptor systems.

As a lipid-modified dual-agonist peptide, Survodutide exhibits physicochemical properties distinct from short linear peptides and unmodified incretin hormones, allowing researchers to examine receptor engagement, peptide persistence, and coordinated signaling dynamics in vitro without reliance on full-length native hormones. Its defined sequence and reproducible synthetic profile support controlled use in mechanistic assays, comparative peptide studies, and exploratory biochemical research conducted under controlled laboratory conditions. This material is intended strictly for laboratory research use only and is not designed for human or veterinary application.